BIO-Europe Spring® 2017: Commercializing cell and gene therapies

April 4, 2017

New business models for clinical development and manufacturing require strategic partnerships among researchers, manufacturers and payers to fully realize the commercial opportunities.

Click here for more coverage of the activities held during BIO-Europe Spring

Previous Article
Report findings provide insight into technological innovations and trends in drug development
Report findings provide insight into technological innovations and trends in drug development

Knect365 Life Sciences has released a report offering unique insights into the awareness, perceptions and i...

Next Video
BIO-Europe Spring® 2017: Partnerships are key for rare disease drug discovery and development
BIO-Europe Spring® 2017: Partnerships are key for rare disease drug discovery and development

What kinds of partnerships are key to getting rare disease research out of the lab and to patients as thera...